Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Week 5-8: 5 mg (0.5 mL or 50 units on an insulin syringe) once weekly
Greene CRL, Blackbourn LAK, McGurnaghan SJ, Mercer SW, Smith DJ, Wild SH, et al
Compared to endogenous GLP-1 and glucagon, retatrutide demonstrates lower potency at GLP-1 and glucagon receptors but substantially higher potency at the human GIP receptor a pharmacological profile deliberately engineered to balance efficacy with tolerability
Results follow a predictable timeline, and our semaglutide results week by week breakdown shows what to expect at each stage
GLP-1 agonists specifically bind to the GLP-1 receptor
This can further support appetite regulation, fullness and blood sugar control
US$ 24.93
US$ 23.92
US$ 24.93
US$ 21.61
US$ 27.82
US$ 28.65
